TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10761179

Group type: EXPERIMENTAL
Intervention: Reminiscence condition
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Enhanced condition
Number of subjects: 43
Study: 9552823

Group type: EXPERIMENTAL
Intervention: Magnets
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ball attachments
Number of subjects: 36

Group type: COMPARATOR
Intervention: Straight bars (reference group)
Number of subjects: 36
Study: 8418171

Group type: EXPERIMENTAL
Intervention: Intestinal microsporidiosis (Enterocytozoon bieneusi)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Patients with intestinal microsporidiosis
Number of subjects: 18
Study: 3745702

Group type: EXPERIMENTAL
Intervention: Indwelling electrode catheter
Number of subjects: 24
Study: 28829958

Group type: EXPERIMENTAL
Intervention: 6-session brief family-based intervention (BFBI)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Relaxation exercises (RE)
Number of subjects: 64
Study: 26694878

Group type: EXPERIMENTAL
Intervention: Experimental treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 24001291

Group type: EXPERIMENTAL
Intervention: Methadone maintenance treatment (MMT)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Pre-treatment predictors
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: In-treatment predictors
Number of subjects: 145
Study: 22115993

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 444

Group type: COMPARATOR
Intervention: Control group (non-diabetic patients)
Number of subjects: 444
Study: 20687121

Group type: EXPERIMENTAL
Intervention: Amantadine 200mg/day
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 18211998

Group type: EXPERIMENTAL
Intervention: Rectal acetaminophen 40 mg kg(‐1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous acetaminophen 15 mg kg(‐1)
Number of subjects: 50
Study: 15864237

Group type: EXPERIMENTAL
Intervention: ACS trial
Number of subjects: 31500

Group type: EXPERIMENTAL
Intervention: CHF trial
Number of subjects: 31500

Group type: EXPERIMENTAL
Intervention: Both trials
Number of subjects: 31500
Study: 12757988

Group type: EXPERIMENTAL
Intervention: Repaglinide (2-4 mg/day)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Metformin (1500-2500 mg/day)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 112
Study: 10490724

Group type: EXPERIMENTAL
Intervention: Filgrastim (G‐CSF) administered subcutaneously at a dose of 5 microg/kg body weight/day from day +5 after PBSC infusion
Number of subjects: 62

Group type: COMPARATOR
Intervention: No cytokines (control group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Filgrastim (G‐CSF)
Number of subjects: 62
Study: 8936390

Group type: EXPERIMENTAL
Intervention: Patients with schizophrenia, schizophreniform disorder, and affective disorder
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: First-degree relatives of patients
Number of subjects: 394

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 394
Study: 1770184

Group type: EXPERIMENTAL
Intervention: Psychostimulants (two doses)
Number of subjects: 9
Study: 6792958

Group type: EXPERIMENTAL
Intervention: Jejunal feeding of elemental diet (ED)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Isotonic intravenous infusions of dextrose (IV)
Number of subjects: 34
Study: 31984655

Group type: EXPERIMENTAL
Intervention: eluxadoline 100 mg twice daily
Number of subjects: 1615

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1615
Study: 30727840

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy
Number of subjects: 125

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Union of baseline ischemic core and follow-up Tmax >6s perfusion volume
Number of subjects: 125
Study: 28061783

Group type: EXPERIMENTAL
Intervention: Mentoring with case sheets/checklists
Number of subjects: 295

Group type: COMPARATOR
Intervention: Case sheets only (Control)
Number of subjects: 295
Study: 25057916

Group type: EXPERIMENTAL
Intervention: Surgical technique for whistler deformity repair
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (preoperatory measurements)
Number of subjects: 38
Study: 23169470

Group type: EXPERIMENTAL
Intervention: Aged garlic extract (2 capsules daily, 480 mg containing 1.2 mg of S-allylcysteine)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Aged garlic extract (4 capsules daily, 960 mg containing 2.4 mg of S-allylcysteine)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Aged garlic extract (1 capsule daily, 240 mg containing 0.6 mg of S-allylcysteine)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 21215788

Group type: EXPERIMENTAL
Intervention: Chlorhexidine MMP-inhibitor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biomimetic remineralisation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No chlorhexidine (control)
Number of subjects: 0
Study: 18443967

Group type: EXPERIMENTAL
Intervention: Computerized face-specific training protocol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 10
Study: 17003731

Group type: EXPERIMENTAL
Intervention: Electromyographic (EMG) responses from the facial nerve in experienced implant users (Nucleus 24)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Postoperative EABR recordings
Number of subjects: 165
Study: 12706515

Group type: EXPERIMENTAL
Intervention: Diagnostic assessment for panic disorder and acute adjustment disorder with anxiety
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Inclusion of assessment for phobia
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Previous history of an anxiety disorder
Number of subjects: 764
Study: 10938684

Group type: EXPERIMENTAL
Intervention: Fibrinolytic agent (n = 43)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Anticoagulant agent (n = 4)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Neuroprotective drugs (n = 25)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Overall treatment expectations
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Informed consent process
Number of subjects: 72
Study: 8653992

Group type: EXPERIMENTAL
Intervention: Oral TPGS (2.6 IU/kg) with cyclosporine (10mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oral cyclosporine (10mg/kg) without TPGS
Number of subjects: 10
Study: 1306665

Group type: EXPERIMENTAL
Intervention: Oral indomethacin, 1 mg/kg per dose, three times a day for 7 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral chloramphenicol, 30 mg/kg per day, in four divided doses for 7 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oral indomethacin, 1 mg/kg per dose, three times a day for 7 days (after chloramphenicol)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Indomethacin treatment
Number of subjects: 30
Study: 6391137

Group type: EXPERIMENTAL
Intervention: Aquarium contemplation
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Aquarium contemplation with hypnosis
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Poster contemplation with hypnotic induction
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Contemplation of a poster
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non intervention control
Number of subjects: 42
Study: 30020461

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination detemir plus liraglutide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study: 28805669

Group type: EXPERIMENTAL
Intervention: Mediterranean diet with antioxidant supplementation (Group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mediterranean diet alone (Group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment (Group C)
Number of subjects: 50
Study: 26630353

Group type: EXPERIMENTAL
Intervention: s-DRY (dry swabs)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: s-FTA (FTA cartridge)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Dr-WET (liquid-based medium)
Number of subjects: 130
Study: 23163410

Group type: EXPERIMENTAL
Intervention: High relatedness proportion condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low relatedness proportion condition
Number of subjects: 0
Study: 22003975

Group type: EXPERIMENTAL
Intervention: Online Insomnia Severity Index (ISI)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Paper-and-pencil Insomnia Severity Index (ISI)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Participants not receiving the parent study intervention
Number of subjects: 43
Study: 18692358

Group type: EXPERIMENTAL
Intervention: Radioguided occult lesion localization (ROLL) with intra-tumoral injection of Tc99m-labelled macro-aggregate albumin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Simultaneous sentinel node biopsy with Tc99m-labelled nanocolloids via periareolar-subdermal injection
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ROLL and sentinel node biopsy combined
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Radical excision for invasive ductal cancer
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Radical excision for DCIS
Number of subjects: 100
Study: 16864466

Group type: EXPERIMENTAL
Intervention: Therapeutic case management
Number of subjects: 90

Group type: COMPARATOR
Intervention: No case management (Control)
Number of subjects: 90
Study: 12877899

Group type: EXPERIMENTAL
Intervention: MATISSE endotoxin adsorption system
Number of subjects: 145
Study: 11204259

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9197878

Group type: EXPERIMENTAL
Intervention: Oestradiol implantation
Number of subjects: 12
Study: 1416323

Group type: EXPERIMENTAL
Intervention: 857 mg/kg sodium polystyrene sulfonate in 4 mL water/g sodium polystyrene sulfonate (experimental)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water without sodium polystyrene sulfonate (control)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 6
Study: 2863754

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 29747310

Group type: EXPERIMENTAL
Intervention: PEG-rhG-CSF
Number of subjects: 0

Group type: COMPARATOR
Intervention: rhG-CSF
Number of subjects: 0
Study: 26107532

Group type: EXPERIMENTAL
Intervention: Physical Activity Integration Program (3 lessons per week for 6 weeks)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (regular mathematics program)
Number of subjects: 240
Study: 24420155

Group type: EXPERIMENTAL
Intervention: Cementless total knee arthroplasty (TKA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cemented total knee arthroplasty (TKA)
Number of subjects: 80
Study: 22569957

Group type: EXPERIMENTAL
Intervention: S/CRT (postoperative chemoradiation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: CRT (definitive chemoradiation)
Number of subjects: 20
Study: 20142756

Group type: EXPERIMENTAL
Intervention: Preoperative biliary drainage (PBD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cholestatic patients (before PBD)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cholestatic patients (after PBD)
Number of subjects: 24
Study: 18783359

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 17036555

Group type: EXPERIMENTAL
Intervention: Pyridostigmine
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Diethyltoluamide
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Permethrin
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Stress condition
Number of subjects: 64

Group type: COMPARATOR
Intervention: Physical and neurocognitive performance
Number of subjects: 64
Study: 14740529

Group type: EXPERIMENTAL
Intervention: Low power laser stimulation of acupuncture points for 10 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no laser stimulation)
Number of subjects: 50
Study: 10756963

Group type: EXPERIMENTAL
Intervention: Priming dose of 15 micrograms/kg cisatracurium followed after 4 min by 85 micrograms/kg cisatracurium
Number of subjects: 51

Group type: COMPARATOR
Intervention: Bolus of 100 micrograms/kg cisatracurium
Number of subjects: 51
Study: 9082075

Group type: EXPERIMENTAL
Intervention: Triptoreline depot (75 micrograms/kg/28 days/i.m.)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (6 untreated girls with advanced puberty and good predicted adult height)
Number of subjects: 14
Study: 1610579

Group type: EXPERIMENTAL
Intervention: Andrews spinal surgery frame
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cloward surgical saddle
Number of subjects: 18

Group type: COMPARATOR
Intervention: Longitudinal bolsters
Number of subjects: 18
Study: 6092410

Group type: EXPERIMENTAL
Intervention: L5‐OH‐triptophan (20 mg iv)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: L5‐OH‐triptophan (40 mg iv)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: L5‐OH‐triptophan (200 mg orally)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: L5‐OH‐triptophan (400 mg orally)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fluoxetine (15 mg orally)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fluoxetine (30 mg orally)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Methysergide (3 X 2.8 mg orally)
Number of subjects: 18
Study: 30281066

Group type: EXPERIMENTAL
Intervention: GBS III-TT conjugate vaccine
Number of subjects: 650

Group type: COMPARATOR
Intervention: Tetanus diphtheria toxoid vaccine
Number of subjects: 650
Study: 29524199

Group type: EXPERIMENTAL
Intervention: air-Q SP
Number of subjects: 0

Group type: COMPARATOR
Intervention: LMA Classic
Number of subjects: 0
Study: 26174079

Group type: EXPERIMENTAL
Intervention: Experimental Group - two-step etch-and-rinse adhesive technique with oxalic acid pretreatment after acid-etched dentin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control Group - two-step etch-and-rinse adhesive technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 20
Study: 24692847

Group type: EXPERIMENTAL
Intervention: Recombinant human TNF-α
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 22824435

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 3197

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 3197
Study: 20140343

Group type: EXPERIMENTAL
Intervention: Health interventions effective in Western industrialized settings
Number of subjects: 0
Study: 18044192

Group type: EXPERIMENTAL
Intervention: Exercise Plus Program
Number of subjects: 209
Study: 16206346

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 2
Study: 11815957

Group type: EXPERIMENTAL
Intervention: TLC D‐99 (75 mg/m(2))
Number of subjects: 224

Group type: COMPARATOR
Intervention: Doxorubicin (75 mg/m(2))
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: TLC D‐99
Number of subjects: 224

Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 224
Study: 9952144

Group type: EXPERIMENTAL
Intervention: Fentanyl 3 ng/ml
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Fentanyl 6 ng/ml
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Sevoflurane/N2O group with increasing concentrations of fentanyl
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Sevoflurane group with increasing concentrations of fentanyl
Number of subjects: 226
Study: 7749156

Group type: COMPARATOR
Intervention: CAF (Cyclophosphamide, Adriamycin, and 5-Fluorouracil)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CNF (Cyclophosphamide, Mitoxantrone, and 5-Fluorouracil)
Number of subjects: 100
Study: 2248757

Group type: EXPERIMENTAL
Intervention: Bopindolol (1 mg once daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Atenolol (100 mg once daily)
Number of subjects: 8
Study: 7362725

Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 80
Study: 31173341

Group type: EXPERIMENTAL
Intervention: Combined dose of 50-60 min of aerobic and resistance exercise (COMB)
Number of subjects: 301
Study: 31336456

Group type: EXPERIMENTAL
Intervention: Radiofrequency and Ultrasound (RF/US) combined with a low calorie diet, administered twice a week for 5 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low calorie diet only
Number of subjects: 50
Study: 28225567

Group type: EXPERIMENTAL
Intervention: Telepractice care
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 82
Study: 25662592

Group type: EXPERIMENTAL
Intervention: F(ab')₂ (0.85 U/kg body weight)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 16
Study: 23582868

Group type: EXPERIMENTAL
Intervention: Switch to another SSRI or venlafaxine, with or without the addition of cognitive behavior therapy (CBT)
Number of subjects: 0
Study: 21669557

Group type: EXPERIMENTAL
Intervention: Chimney woodstove intervention
Number of subjects: 119

Group type: COMPARATOR
Intervention: Open fire use (control)
Number of subjects: 119
Study: 19255287

Group type: EXPERIMENTAL
Intervention: PF-PCT
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: S-PCT
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: PF-PCT and S-PCT
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: PF-PCT/S-PCT ratio
Number of subjects: 82
Study: 17822340

Group type: EXPERIMENTAL
Intervention: Atomoxetine once daily
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo once daily
Number of subjects: 106
Study: 15017228

Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 11483141

Group type: EXPERIMENTAL
Intervention: naltrexone treatment plus contingency management (CM)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: naltrexone treatment, CM, plus significant other involvement (SO)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: significant other involvement (SO)
Number of subjects: 127

Group type: COMPARATOR
Intervention: standard naltrexone treatment
Number of subjects: 127
Study: 9740088

Group type: COMPARATOR
Intervention: MET + DEX (10 mg*4 and 2 mg*1, orally)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: TRO (5 mg*1, orally)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: TRO + MET (5 mg*1 and 10 mg*2, orally)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: TRO + MET + DEX (5 mg*1, 10 mg*2, and 2 mg*1, orally)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: CHL + DEX (25 mg*2 and 2 mg*1, orally)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: TRO + CHL (5 mg*1 and 12.5 mg*2, orally)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: TRO + CHL + DEX (5 mg*1, 12.5 mg*2, and 2 mg*1, orally)
Number of subjects: 280
Study: 7980668

Group type: EXPERIMENTAL
Intervention: Ice chips
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nitrogen cold air
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Ligno-paraffin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo short wave diathermy
Number of subjects: 39
Study: 2608537

Group type: EXPERIMENTAL
Intervention: Low-fat diet (20% energy from fat)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard western diet (40% energy from fat)
Number of subjects: 0
Study: 1126780

Group type: EXPERIMENTAL
Intervention: Trimethylpsoralen
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Psoralen
Number of subjects: 89

Group type: COMPARATOR
Intervention: 8-methoxypsoralen
Number of subjects: 89
Study: 30367952

Group type: EXPERIMENTAL
Intervention: 10Hz-tACS
Number of subjects: 22

Group type: COMPARATOR
Intervention: tDCS
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 22
Study: 28797456

Group type: EXPERIMENTAL
Intervention: Rebamipide gargle
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo gargle
Number of subjects: 60
Study: 24856460

Group type: EXPERIMENTAL
Intervention: fMRI alone for localization of epilepsy related hemodynamic foci
Number of subjects: 26
Study: 23717666

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 57
Study: 20630604

Group type: EXPERIMENTAL
Intervention: Explicit instruction
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal instruction
Number of subjects: 20
Study: 18824499

Group type: EXPERIMENTAL
Intervention: NNBC-3 risk classification algorithm
Number of subjects: 410

Group type: COMPARATOR
Intervention: Adjuvant!
Number of subjects: 410

Group type: COMPARATOR
Intervention: St Gallen risk classification
Number of subjects: 410
Study: 16885182

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1200 mg daily for 14 days)
Number of subjects: 902

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 902
Study: 14687223

Group type: EXPERIMENTAL
Intervention: SRP + SDD (20 mg bid)
Number of subjects: 32

Group type: COMPARATOR
Intervention: SRP + placebo (20 mg bid)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 11757712

Group type: EXPERIMENTAL
Intervention: Combined modality therapy (CMT)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 2

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 2
Study: 9476468

Group type: EXPERIMENTAL
Intervention: Nicotine plus cisapride (5 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nicotine patch (14 mg/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7958682

Group type: EXPERIMENTAL
Intervention: 2.5 g of fish oil per day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5.1 g of fish oil per day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 7.7 g of fish oil per day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2.5 g of fish oil per day (in subsequent study with 15 patients)
Number of subjects: 60
Study: 3665190

Group type: EXPERIMENTAL
Intervention: Non-meat substitute (vegetable protein)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Meat substitute
Number of subjects: 64